TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20023346

Group type: EXPERIMENTAL
Intervention: External oblique abdominis muscle activation during loading 12 kg in flexed trunk position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Internal oblique abdominis muscle activation during loading 6 and 12 kg in neutral trunk position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Electrical activity of back muscles during trunk flexion with highest external load
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Activation of Rectus abdominis muscle in patients with CLBP during increasing load
Number of subjects: 20

Group type: COMPARATOR
Intervention: Activation of Rectus abdominis and Internal oblique muscles in healthy subjects during increasing load
Number of subjects: 20
Study: 17540215

Group type: EXPERIMENTAL
Intervention: Inhaled iloprost
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Flow-mediated dilation (FMD) in IPAH patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nitroglycerin-mediated dilation in IPAH patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Correlation of FMD with PVRII
Number of subjects: 18
Study: 15384808

Group type: EXPERIMENTAL
Intervention: ACEI (oral)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ARB (oral)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ca channel blocker
Number of subjects: 36
Study: 12891152

Group type: EXPERIMENTAL
Intervention: Problem-based learning (PBL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lecture-based case format
Number of subjects: 32
Study: 10626618

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (child only)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (mother only)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (mother and child)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Community comparison condition
Number of subjects: 100
Study: 8748193

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) for three 3‐h periods daily
Number of subjects: 5

Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both limbs (CPM and Control)
Number of subjects: 5
Study: 2202511

Group type: EXPERIMENTAL
Intervention: Ceftizoxime (1 gm single dose)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cefoxitin (3 doses of 2 gm)
Number of subjects: 62
Study: 7285499

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no indomethacin)
Number of subjects: 8
Study: 30740991

Group type: EXPERIMENTAL
Intervention: Worry postponement intervention (postponing worries to a 30-minute period in the evening)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 114
Study: 28857336

Group type: EXPERIMENTAL
Intervention: 8 weeks of periodized aerobic training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (20 matched subjects, age 64 ± 5 years; FEV1 %pred 113 ± 16%)
Number of subjects: 24
Study: 25643859

Group type: EXPERIMENTAL
Intervention: 1-hour online auditory training programme
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 1-year mastery-style reinforcement programme
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 162
Study: 24452619

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 106

Group type: COMPARATOR
Intervention: TVT-S
Number of subjects: 106
Study: 22976263

Group type: EXPERIMENTAL
Intervention: High-flux dialysis membranes
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low-flux dialysis membranes
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (40 volunteers)
Number of subjects: 80
Study: 19528280

Group type: EXPERIMENTAL
Intervention: PA-824 (1,500 mg single dose)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: PA-824 (600 mg multiple doses)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: PA-824 (up to 7 days of daily dosing)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: PA-824 (daily dosing)
Number of subjects: 58
Study: 17582496

Group type: EXPERIMENTAL
Intervention: TOF-MRA
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: CE-MRA
Number of subjects: 33
Study: 15068394

Group type: EXPERIMENTAL
Intervention: OGTT (oral glucose tolerance test; 75 g of glucose)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 12575212

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (no Nifedipine)
Number of subjects: 84
Study: 9261032

Group type: EXPERIMENTAL
Intervention: Abnormal blood pressure responses
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Abnormal heart rate responses
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Combined abnormal blood pressure and heart rate responses
Number of subjects: 71
Study: 8066320

Group type: EXPERIMENTAL
Intervention: Sterile single-use catheters
Number of subjects: 30

Group type: COMPARATOR
Intervention: Clean reused catheters
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sterile catheters only (from a similar group)
Number of subjects: 30
Study: 3557017

Group type: EXPERIMENTAL
Intervention: Sulfated G‐17 infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsulfated G‐17 infusion
Number of subjects: 0
Study: 30506924

Group type: EXPERIMENTAL
Intervention: Mirtazapine transdermal ointment 2 mg/cat, applied once daily for 14 ± 3 days
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo, applied once daily for 14 ± 3 days
Number of subjects: 177
Study: 27939951

Group type: EXPERIMENTAL
Intervention: Personalised exposure testing with feedback on test results
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham exposures
Number of subjects: 42
Study: 25363659

Group type: EXPERIMENTAL
Intervention: Miniarc suburethral sling
Number of subjects: 50

Group type: COMPARATOR
Intervention: Monarc suburethral sling
Number of subjects: 50
Study: 23027226

Group type: EXPERIMENTAL
Intervention: BIS-guided anesthesia
Number of subjects: 921

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 921
Study: 21777873

Group type: EXPERIMENTAL
Intervention: PAS-25 (paired-associative stimulation with PNS preceding TMS by 25 milliseconds)
Number of subjects: 44

Group type: COMPARATOR
Intervention: PAS-10 (paired-associative stimulation with PNS preceding TMS by 10 milliseconds)
Number of subjects: 44
Study: 19472848

Group type: EXPERIMENTAL
Intervention: Decompressive surgery plus prednisolone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 88
Study: 17329128

Group type: EXPERIMENTAL
Intervention: Dopamine administration
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Believers in the paranormal
Number of subjects: 35

Group type: COMPARATOR
Intervention: Skeptics
Number of subjects: 35
Study: 14666372

Group type: EXPERIMENTAL
Intervention: Radner Reading Charts (three standardized charts)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Variance component analyses
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Radner Reading Charts
Number of subjects: 36
Study: 11520726

Group type: EXPERIMENTAL
Intervention: Endotoxin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ibuprofen (cyclooxygenase inhibitor)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9779520

Group type: EXPERIMENTAL
Intervention: REM-deprivation (RD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Yoked-control (YC)
Number of subjects: 26
Study: 7899118

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 2 mg/kg IV
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) and Placebo (P)
Number of subjects: 88
Study: 3108981

Group type: EXPERIMENTAL
Intervention: Distilled water
Number of subjects: 12

Group type: COMPARATOR
Intervention: DSCG in distilled water
Number of subjects: 12

Group type: COMPARATOR
Intervention: DSCG in normal saline
Number of subjects: 12

Group type: COMPARATOR
Intervention: DSCG in buffered saline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Coughing during inhalation of nebulised distilled water
Number of subjects: 12
Study: 2123287

Group type: EXPERIMENTAL
Intervention: BPF clone infection
Number of subjects: 10
Study: 60065

Group type: EXPERIMENTAL
Intervention: Dextran
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gelatins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma substitutes (general)
Number of subjects: 0
Study: 31122895

Group type: EXPERIMENTAL
Intervention: Advance care planning and palliative care interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised trials of interventions to improve communication about goals of care
Number of subjects: 0
Study: 28138946

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0
Study: 26063454

Group type: EXPERIMENTAL
Intervention: Abatacept plus MTX
Number of subjects: 419

Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 419
Study: 23472459

Group type: EXPERIMENTAL
Intervention: Argan oil
Number of subjects: 151

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 151
Study: 21468376

Group type: EXPERIMENTAL
Intervention: Intravenous cefuroxime 1500 mg given as preoperative antimicrobial prophylaxis 30 minutes prior to surgery
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 19431956

Group type: EXPERIMENTAL
Intervention: Ethyl cyanoacrylate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 24
Study: 16705719

Group type: EXPERIMENTAL
Intervention: 20 mg alendronate for 2 months and 10 mg for 2 months thereafter
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 20 mg alendronate for 2 months and 10 mg for 4 months thereafter
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 14740310

Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol-LCT with pre-treatment of lidocaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT with pre-treatment of lidocaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol-LCT
Number of subjects: 80
Study: 11501728

Group type: EXPERIMENTAL
Intervention: Physical therapy (ice massage or wax packs, thermal baths, and faradic hand baths)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no physical or exercise therapy)
Number of subjects: 50
Study: 9243041

Group type: EXPERIMENTAL
Intervention: Stopping antibiotic therapy on day 3 (group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Continuing antibiotic therapy (group B)
Number of subjects: 68
Study: 8281594

Group type: EXPERIMENTAL
Intervention: Armoured laryngeal mask airway (LMA)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Tracheal intubation (ETT)
Number of subjects: 109
Study: 3570863

Group type: EXPERIMENTAL
Intervention: Riboflavin supplement
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29587673

Group type: EXPERIMENTAL
Intervention: Breastfeeding: Essential Support Skills DVD
Number of subjects: 210

Group type: COMPARATOR
Intervention: Vaginal delivery DVD
Number of subjects: 210
Study: 28545578

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) involving eight workshops lasting 1.5 hours each, conducted weekly for 8 weeks.
Number of subjects: 96
Study: 26136584

Group type: EXPERIMENTAL
Intervention: Water and education provision (WEP) group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Education provision (EP) only group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: WEP group with high water intake (>1200 mL/d)
Number of subjects: 240
Study: 23670566

Group type: EXPERIMENTAL
Intervention: Depression services use in various settings (primary care, mental health, substance abuse, homeless services, social services)
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Counseling for depression treatment
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Community-based depression care
Number of subjects: 981
Study: 21172952

Group type: EXPERIMENTAL
Intervention: BI 44370 TA 400 mg
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 461

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: BI 44370 TA 200 mg
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: BI 44370 TA 50 mg
Number of subjects: 461
Study: 18583261

Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg/day)
Number of subjects: 118

Group type: COMPARATOR
Intervention: sulfonylureas
Number of subjects: 118
Study: 16247610

Group type: EXPERIMENTAL
Intervention: Clotrimazole 100 mg vaginal pessaries for 6 days, 2 gm secnidazole, and 150 mg fluconazole as single therapy.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Clotrimazole 100 mg vaginal pessaries for 6 days, combination kit containing 150 mg fluconazole, 2 gm secnidazole, and 1 gm azithromycin.
Number of subjects: 72
Study: 12235022

Group type: EXPERIMENTAL
Intervention: Monosodium glutamate (MSG) 150 mg/kg body weight
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 10217372

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (one tablet/day)
Number of subjects: 24
Study: 8610776

Group type: EXPERIMENTAL
Intervention: Endocervical prostaglandin E2 gel
Number of subjects: 285

Group type: COMPARATOR
Intervention: Vaginal prostaglandin E2 gel
Number of subjects: 285
Study: 1970961

Group type: EXPERIMENTAL
Intervention: Fenoldopam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 540079

Group type: EXPERIMENTAL
Intervention: Tinidazole 40-50 mg/kg for 3 days
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Tinidazole 100 mg coated tablets
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Tinidazole 40-50 mg/kg
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Tinidazole for G. lamblia infections
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Tinidazole for E. histolytica infections
Number of subjects: 360
Study: 30016633

Group type: EXPERIMENTAL
Intervention: Dilute intravesical contrast followed by sterile saline
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-dilute intravesical contrast
Number of subjects: 48
Study: 26985727

Group type: EXPERIMENTAL
Intervention: Family‐ and church‐based intervention
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124
Study: 25424918

Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 437
Study: 22670574

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy program
Number of subjects: 39
Study: 19969423

Group type: EXPERIMENTAL
Intervention: Adherent protocol (HDS with gauze as secondary covering)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Gelled protocol (HDS with transparent film as secondary covering)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Adherent protocol
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Gelled protocol
Number of subjects: 70
Study: 17590368

Group type: EXPERIMENTAL
Intervention: Mud-bath treatment (12 mud packs and 12 thermal baths over a period of two weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no mud-bath treatment)
Number of subjects: 24
Study: 15452586

Group type: EXPERIMENTAL
Intervention: SNP rs1136141 in HSPA8
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control group (1025 controls)
Number of subjects: 288
Study: 12102471

Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 117

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 117
Study: 10460040

Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin
Number of subjects: 400

Group type: COMPARATOR
Intervention: Interferon alpha‐2b alone
Number of subjects: 400
Study: 7791257

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 262

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 262
Study: 2112337

Group type: EXPERIMENTAL
Intervention: ISDN spray, 2.5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: sublingual NTG, 0.8 mg
Number of subjects: 12
Study: 91774

Group type: EXPERIMENTAL
Intervention: Vaccinated group (polyvalent pseudomonas vaccine)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 107
Study: 31401603

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy (HFOT) alone
Number of subjects: 280

Group type: COMPARATOR
Intervention: High-flow nasal oxygen therapy (HFOT) with non-invasive ventilation (NIV)
Number of subjects: 280
Study: 27860460

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 25730661

Group type: EXPERIMENTAL
Intervention: Demonstration-based training
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Simulation participation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Didactic instruction
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 52
Study: 24378660

Group type: EXPERIMENTAL
Intervention: 30 Hz
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: I-Freq
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 12
Study: 21955688

Group type: EXPERIMENTAL
Intervention: DBSint®
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: SINTlife®
Number of subjects: 31

Group type: COMPARATOR
Intervention: lyophilised bone chips
Number of subjects: 31
Study: 19296949

Group type: EXPERIMENTAL
Intervention: Changing position and early ambulation after cardiac catheterization
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine management with 10-24h bed rest in supine position
Number of subjects: 70
Study: 17475960

Group type: EXPERIMENTAL
Intervention: (18)F‐FLT PET
Number of subjects: 10
Study: 15044426

Group type: EXPERIMENTAL
Intervention: Antimicrobial management programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intensive care areas
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive care areas
Number of subjects: 0
Study: 12532614

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate (1 or 2 drops applied directly on the incision)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional nylon suturing (Control Group)
Number of subjects: 60
Study: 9583331

Group type: EXPERIMENTAL
Intervention: Residential treatment
Number of subjects: 261

Group type: COMPARATOR
Intervention: Day treatment
Number of subjects: 261
Study: 2069605

Group type: EXPERIMENTAL
Intervention: Fitness program (details not specified)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Demographic and social characteristics (gender, income, ethnicity)
Number of subjects: 48
Study: 6364459

Group type: EXPERIMENTAL
Intervention: doxorubicin + cyclophosphamide + vincristine
Number of subjects: 100

Group type: COMPARATOR
Intervention: CCNU + vincristine
Number of subjects: 100
Study: 30793285

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Placebo/Standard of Care
Number of subjects: 1037
Study: 29669181

Group type: COMPARATOR
Intervention: Arm A (70 Gy of radiation with cisplatin)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Arm B (70 Gy of radiation with cisplatin plus erlotinib at 150 mg daily)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Black race (independent predictor)
Number of subjects: 189
Study: 26812050

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 57
Study: 24598885

Group type: EXPERIMENTAL
Intervention: Vitamin B-12 supplementation (50 μg daily)
Number of subjects: 366
Study: 22856186

Group type: EXPERIMENTAL
Intervention: Gel-bead delivery of Eimeria oocysts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral gavage of Eimeria oocysts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spray vaccination with Eimeria oocysts mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonimmunized control group
Number of subjects: 0
Study: 20738316

Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin (5 pmol/kg/min)
Number of subjects: 21
Study: 18422391

Group type: EXPERIMENTAL
Intervention: High-dose valsartan 160-320 mg/day
Number of subjects: 450

Group type: COMPARATOR
Intervention: Low-dose valsartan 80 mg/day (VALVACE trial)
Number of subjects: 450
Study: 15858804

Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 0
Study: 12519437

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBC with low residual WBC concentration
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBC with middle residual WBC concentration
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBC with high residual WBC concentration
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison between middle and high residual WBC groups
Number of subjects: 105
Study: 10648316

Group type: EXPERIMENTAL
Intervention: 12-mL bolus dose with a 25-min lockout interval
Number of subjects: 203

Group type: COMPARATOR
Intervention: 4-mL bolus dose with an 8-min lockout interval
Number of subjects: 203
Study: 9017785

Group type: EXPERIMENTAL
Intervention: 5-lipoxygenase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cysLT receptor antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-lipoxygenase inhibitors and cysLT receptor antagonists
Number of subjects: 0
Study: 8382228

Group type: EXPERIMENTAL
Intervention: pyrophosphate containing cleaning gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo gel
Number of subjects: 30
Study: 3017551

Group type: EXPERIMENTAL
Intervention: Carmustine (BCNU) - 80 mg/m2 iv daily X 3 every 6 weeks
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Dacarbazine (DTIC) - 175 mg/m2 iv daily X 5 every 4 weeks
Number of subjects: 278

Group type: COMPARATOR
Intervention: Procarbazine (PCB) - 100 mg/m2 orally
Number of subjects: 278